Publications for Troy W. Joseph

School of Health Sciences (New York)
  • Rosado, L. M., Meyerhoefer, T. J., Bett, S. M., Ilyas, S., Bululu, L., Martin, C. A., . . . Joseph, T. W. (2016). Direct coupling of amides and urea to glycosyl halides using silver triflate. European Journal of Organic Chemistry, 16, 2778-2784. doi:10.1002/ejoc.201600350

  • Hui, L., Abbas, T., Pielak, R. M., Joseph, T. W., Bargonetti, J., & Foster, D. A. (2004). Phospholipase D elevates the level of MDM2 and suppresses DNA damage-induced increases in p53. Mollecular and Cell Biology, 24(13), 5677-5686. doi:10.1128/MCB.24.13.5677-5686.2004

  • Joseph, T. W., & Moll, U. M. (2003). Analysis of nuclear and cytoplasmic degradation of p53 in cells after stress. Methods in Molecular Biology, 234, 211-217. doi:10.1385/1-59259-408-5:211

  • Joseph, T. W., Zaika, A., & Moll, U. M. (2003). Nuclear and cytoplasmic degradation of endogenous p53 and HDM2 occurs during down-regulation of the p53 response after multiple types of DNA damage. FASEB Journal, 17, 1622-1630. 

  • Zhong, M., Shen, Y., Zheng, Y., Joseph, T. W., Jackson, D., & Foster, D. A. (2003). Phospholipase D prevents apoptosis in v-Src-transformed rat fibroblasts and MDA-MB-231 breast cancer cells. Biochemical and Biophysical Research Communications, 302(3), 615–619. doi:10.1016/S0006-291X(03)00229-8

  • Joseph, T. W., Bryant, A., Frankel, P., Wooden, R., Kerkhoff, E., Rapp, U. R., & Foster, D. A. (2002). Phospholipase D overcomes cell cycle arrest induced by high-intensity Raf signaling. Oncogene, 21(22), 3651-3658. doi:10.1038/sj.onc.1205380

  • Zaika, A. I., Slade, N., Erster, S. H., Sansome, C., Joseph, T. W., Pearl, M., . . . Moll, U. M. (2002). ΔNp73, a dominant-negative inhibitor of wild-type p53 and TAp73, is up-regulated in human tumors. Journal of Experimental Medicine, 196(6), 765-780. doi:10.1084/jem.20020179

  • Zhong, M., Joseph, T. W., Jackson, D., Beychenok, S., & Foster, D. A. (2002). Elevated phospholipase D activity induces apoptosis in normal rat fibroblasts. Biochemical and Biophysical Research Communications, 298(4), 474-477. doi:10.1016/S0006-291X(02)02495-6

  • Davenport, L., Shen, B., Joseph, T. W., & Straher, M. P. (2001). A novel fluorescent coronenyl-phospholipid analogue for investigations of submicrosecond lipid fluctuations. Chemistry and Physics of Lipids, 109(2), 145-156. doi:10.1016/S0009-3084(00)00214-0

  • Joseph, T. W., Wooden, R., Bryant, A., Zhong, M., Lu, A., & Foster, D. A. (2001). Transformation of cells overexpressing a tyrosine kinase by phospholipase D1 and D2. Biochemical and Biophysical Research Communications, 289(5), 1019-1024. doi:10.1006/bbrc.2001.6118

  • Lu, Z., Hornia, A., Joseph, T., Sukezane, T., Frankel, P., Zhong, M., . . . Foster, D. A. (2000). Phospholipase D and RalA cooperate with the epidermal growth factor receptor to transform 3Y1 rat fibroblasts. Molecular and Cellular Biology, 20(2), 462-467. doi:10.1128/MCB.20.2.462-467.2000

  • Xu, L., Shen, Y., Joseph, T. W., Bryant, A., Luo, J. Q., Frankel, P., . . . Foster, D. A. (2000). Mitogenic phospholipase D activity is restricted to caveolin-enriched membrane microdomains. Biochemical and Biophysical Research Communications, 273(1), 77-83. doi:10.1006/bbrc.2000.2907

  • Frankel, P., Ramos, M., Flom, J., Bychenok, S., Joseph, T. W., Kerkhoff, E., . . . Foster D. A. (1999). Ral and Rho-dependent activation of phospholipase D in v-Raf-transformed cells. Biochemical and Biophysical Research Communications, 255(2), 502-7. doi:10.1006/bbrc.1999.0234

  • Hornia, A., Lu, Z., Sukezane, T., Zhong, M., Joseph, T., Frankel, P., & Foster, D. A. (1999). Antagonistic effects of protein kinase C alpha and delta on both transformation and phospholipase D activity mediated by the epidermal growth factor receptor. Molecular and Cellular Biology, 19(11), 7672-7680. doi:10.1128/MCB.19.11.7672